For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

MD Healthcare Inc.

Calculating rank

USPTO Granted Patents = 31

% Expired Patents = 3.2

EPO Patents = 19

Forward Citations = 10

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Yoon-Keun Kim (31 out of 38 patents)

Young Koo Jee (3 out of 3 patents)

Young-Ju Kim (2 out of 44 patents)

4. Mina Rho (2 out of 2 patents)

5. Minhye Kim (2 out of 2 patents)

6. Tae Seop Shin (1 out of 1 patent)

7. Hyun-Taek Park (1 out of 1 patent)

8. Changill Ban (1 out of 7 patents)

9. Jinseong Jeon (1 out of 1 patent)

10. Hanki Park (1 out of 1 patent)

11. Chang Mo Moon (1 out of 4 patents)

12. Byung-In Moon (1 out of 1 patent)

13. Bok Yang Pyun (1 out of 1 patent)

14. Jun-Pyo Choi (1 out of 1 patent)

15. Hyeonil Choi (1 out of 1 patent)

Core Competencies:

Nanovesicles

Bacteria

Metagenomic Analysis

Neurological Disorders

Inflammatory Diseases

Extracellular Vesicles

Diagnostic Methods

Cancer Treatment

Viral Infections

Mental Disorders

Ocular Diseases

Pathogen Identification

31 patents: Sort by Forward Citations

1. 12312636 - Nanovesicles derived from genusbacteria and use thereof (2025-05-27),

2. 12097227 - Nanovesicles derived from bacteria ofgenus and use thereof (2024-09-24),

3. 12084721 - Inflammatory bowel disease diagnostic method by means of bacterial metagenomic analysis (2024-09-10),

4. 12018337 - Nano-vesicle derived from catenibacterium bacteria and use thereof (2024-06-25),

5. 11992509 - Composition for prevention or treatment of neurodevelopmental disorder, neurologic diseases, or psychiatric diseases comprising extracellular vesicles derived from (2024-05-28),

6. 11944652 - Nano-vesicles derived from genusbacteria and use thereof (2024-04-02),

7. 11898156 - Nano-vesicles derived from genusbacteria and use thereof (2024-02-13),

8. 11883440 - Nanovesicle derived fromgenus bacteria, and use thereof (2024-01-30),

9. 11827939 - Method for diagnosing cholangiocarcinoma via bacterial metagenomic analysis (2023-11-28),

10. 11771742 - Nano-vesicles derived from genus cupriavidus bacteria and use thereof (2023-10-03),

11. 11708615 - Method for diagnosing lymphoma via bacterial metagenomic analysis (2023-07-25),

12. 11708611 - Method for diagnosing prostatic disease via bacterial metagenomic analysis (2023-07-25),

13. 11672838 - Composition for prevention or treatment of neurological or mental disorders comprising extracellular vesicles derived from (2023-06-13),

14. 11666608 - Composition for prevention or treatment of ocular diseases comprising extracellular vesicles derived from (2023-06-06),

15. 11666607 - Nanovesicles derived fromand uses thereof (2023-06-06),

Company Overview

MD Healthcare Inc. is a South Korean company specializing in the development and manufacturing of advanced medical devices and healthcare solutions. The organization focuses on innovative technologies that enhance patient care and improve clinical outcomes. With a commitment to research and development, MD Healthcare aims to address the evolving needs of the healthcare industry, leveraging expertise in areas such as diagnostics, monitoring systems, and therapeutic devices to deliver effective solutions for healthcare providers and patients alike.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

31 Patents

#168 in Seoul

#443 in South Korea

#21,301 in the World

Seoul, South Korea

MD Healthcare Inc.

Forward Citations = 10

20 inventors:

Yoon-Keun Kim (31 out of 38 patents)

Young Koo Jee (3 out of 3 patents)

Young-Ju Kim (2 out of 44 patents)

4. Mina Rho (2 out of 2 patents)

5. Minhye Kim (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: MD Healthcare Inc.. Retrieved from https://idiyas.com/company/md-healthcare

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…